Copyright
©The Author(s) 2016.
World J Diabetes. Oct 15, 2016; 7(18): 441-448
Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.441
Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.441
Table 2 Post-treatment (3-mo) body weight parameters[24]
| BMI (kg/m2) | Body weight (kg) | WC (cm) | |
| Metformin | 36.1 ± 3.8 | 102 ± 6.8 | 120.7 ± 7.8 |
| Liraglutide | 37.6 ± 5.1 | 105.1 ± 13.8 | 121.7 ± 9.6 |
| COMBI | 35.5 ± 5.5 | 99.0 ± 21.2 | 116.4 ± 18.4 |
- Citation: Chatterjee S, Ghosal S, Chatterjee S. Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome. World J Diabetes 2016; 7(18): 441-448
- URL: https://www.wjgnet.com/1948-9358/full/v7/i18/441.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i18.441